Amylyx Pharmaceuticals, Inc. AMLX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.
The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amylyx Pharmaceuticals, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amylyx Pharmaceuticals, Inc.'s enterprise value?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported enterprise value of $1.31B in Q1 2026.
- How has Amylyx Pharmaceuticals, Inc.'s enterprise value changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s enterprise value increased by 414.3% year-over-year, from $255.27M to $1.31B.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s enterprise value?
- Over 3 years (2022 to 2025), Amylyx Pharmaceuticals, Inc.'s enterprise value has grown at a -22.3% compound annual growth rate (CAGR), from $2.36B to $1.11B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.